Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Reached Goal on Mounjaro — How Do You Stop Losing Weight?

Someone on a forum says they hit their goal weight while taking Mounjaro (a prescription medication) and wants to know how to stop losing weight and keep it off. They plan to keep eating well and exercising but worry that staying in a calorie deficit will keep shrinking them. They’re asking how others transitioned from active weight loss on the drug to a maintenance phase. Mounjaro is the brand name for tirzepatide. It’s a prescription injectable drug that acts on the brain and body to reduce appetite and help control blood sugar. Put simply: it makes you feel less hungry, can slow how fast food leaves the stomach, and helps lower calorie intake without as much conscious effort. It was developed for diabetes and is also used for weight loss under supervision. It’s not a vitamin or supplement — it’s a powerful medication that changes appetite signals. What people who’ve tried this tend to report — and what clinicians advise — is that maintenance usually means adjusting several things rather than just one. First, many people stop aiming for a calorie deficit and instead shift to a calorie range that matches their new energy needs (maintenance calories). That often requires slowly increasing food intake and watching weight closely for a few weeks. Some people also reduce their dose of the medication under doctor guidance, or stop it if it’s appropriate for them, which can change appetite and weight, so follow-up is important. Note: forum posts are personal stories and individual experiences vary; formal studies show weight can come back if the medication is stopped and lifestyle changes aren’t sustainable. This matters because reaching a goal weight is only half the battle — keeping it off is the other half. If you stay in a deficit, you’ll probably keep losing weight until your body adjusts, which might be unwanted. On the other hand, jumping back to old eating patterns can cause regain. A practical approach is to work with a clinician, dietitian, or weight-management team to calculate your new maintenance calories, plan a gradual increase in intake (for example, 100–200 calories every week or two), monitor weight weekly, and adjust exercise and medication under medical supervision. That helps you find a stable balance where you feel good and the scale stays steady. There are important caveats. Changing dose or stopping Mounjaro should only be done with your prescriber because the drug affects blood sugar and appetite and can have side effects during dose changes. Some people experience weight regain after stopping these medications, which can be discouraging. Side effects while on or after stopping can include nausea, changes in bowel habits, or changes in appetite. Also, long-term safety and the best long-term strategies for maintenance are still being studied. If you have diabetes, other health conditions, or take other medicines, the transition needs closer medical supervision. Bottom line: Don’t try to “keep dieting” forever — plan a gradual switch from calorie deficit to maintenance with professional help, monitor your weight, and discuss any dose changes with your doctor.

Source: r/Mounjaro

Read full story

Back to Riding the pepTIDE